| P50 | author | Frederick R. Appelbaum | Q75025725 |
| P2860 | cites work | Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation | Q28277744 |
| | Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome | Q33560410 |
| | 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. | Q35849468 |
| | Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide | Q35877266 |
| | Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects | Q35959473 |
| | Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia. | Q37036289 |
| | Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates | Q37295150 |
| | Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. | Q40696043 |
| | Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes | Q44175621 |
| | Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission | Q44242611 |
| | Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells | Q44391209 |
| | Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. | Q53532028 |
| | Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant | Q56906662 |
| | Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP. | Q64966447 |
| | Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osse | Q68126425 |
| | Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens | Q68578028 |
| | Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens | Q70138431 |
| | Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission | Q70213396 |
| | Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (S | Q72160221 |
| | A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group | Q72384744 |
| | Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases | Q74106097 |
| | Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome | Q78102284 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 543-550 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Best Practice and Research: Clinical Haematology | Q15755888 |
| P1476 | title | Optimising the conditioning regimen for acute myeloid leukaemia | |
| P478 | volume | 22 | |